Ketoprofen, 50 mg/ml 2 ml 5 pcs

Inflammatory and degenerative diseases of the musculoskeletal system: rheumatoid, psoriatic arthritis, Bechterew disease (ankylosing spondylitis), gouty arthritis, osteoarthritis.

Indications

Inflammatory and degenerative diseases of the musculoskeletal system: rheumatoid, psoriatic arthritis, ankylosing spondylitis, gouty arthritis, osteoarthritis.

Pharmacological effect

Pharmacodynamics

Special instructions

During treatment, monitoring of the peripheral blood picture and the functional state of the liver and kidneys is necessary. If it is necessary to determine 17-ketosteroids, the drug should be discontinued 48 hours before the study.

Active ingredient

Ketoprofen

Composition

1 ml of the drug contains:

Contraindications

Hypersensitivity (including to other NSAIDs);

Side Effects

The incidence of adverse reactions is given in accordance with the WHO classification: very often: >1/10, often: from >1/100 to 1/1000 to 1/10000 to <1/1000, very rarely: from <1/10000, including isolated reports.

Interaction

Pharmaceutically incompatible with tramadol solution. Reduces the effectiveness of uricosuric drugs (drugs), enhances the effect of anticoagulants, antiplatelet agents, fibrinolytics, ethanol, side effects of glucocorticosteroids and mineralocorticosteroids, estrogens; reduces the effectiveness of antihypertensive drugs and diuretics.

Overdose

Symptoms:

Storage conditions

At a temperature not higher than 25°C.

Shelf life

2 years

Manufacturer

Vetprom AD, Bulgaria